State Street’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.84B | Buy |
|
|||||
|
2021
Q1 | $1.51B | Sell |
|
|||||
|
2020
Q4 | $1.66B | Sell |
|
|||||
|
2020
Q3 | $1.27B | Buy |
|
|||||
|
2020
Q2 | $1.24B | Sell |
|
|||||
|
2020
Q1 | $995M | Buy |
|
|||||
|
2019
Q4 | $1.19B | Buy |
|
|||||
|
2019
Q3 | $1.06B | Sell |
|
|||||
|
2019
Q2 | $1.45B | Sell |
|
|||||
|
2019
Q1 | $1.51B | Buy |
|
|||||
|
2018
Q4 | $1.02B | Buy |
|
|||||
|
2018
Q3 | $1.41B | Buy |
|
|||||
|
2018
Q2 | $1.22B | Buy |
|
|||||
|
2018
Q1 | $1.01B | Sell |
|
|||||
|
2017
Q4 | $1.3B | Sell |
|
|||||
|
2017
Q3 | $1.58B | Sell |
|
|||||
|
2017
Q2 | $1.44B | Buy |
|
|||||
|
2017
Q1 | $1.37B | Buy |
|
|||||
|
2016
Q4 | $1.29B | Buy |
|
|||||
|
2016
Q3 | $1.24B | Buy |
|
|||||
|
2016
Q2 | $1.03B | Buy |
|
|||||
|
2016
Q1 | $1.22B | Sell |
|
|||||
|
2015
Q4 | $1.68B | Buy |
|
|||||
|
2015
Q3 | $1.38B | Buy |
|
|||||
|
2015
Q2 | $1.59B | Buy |
|
|||||
|
2015
Q1 | $1.47B | Sell |
|
|||||
|
2014
Q4 | $1.58B | Buy |
|
|||||
|
2014
Q3 | $1.35B | Buy |
|
|||||
|
2014
Q2 | $1.24B | Buy |
|
|||||
|
2014
Q1 | $1.19B | Sell |
|
|||||
|
2013
Q4 | $1.07B | Buy |
|
|||||
|
2013
Q3 | $912M | Buy |
|
|||||
|
2013
Q2 | $715M | Buy |
|